307 related articles for article (PubMed ID: 11607859)
1. [New indications for thalidomide?].
Tuinmann G; Hegewisch-Becker S; Hossfeld DK
Dtsch Med Wochenschr; 2001 Oct; 126(42):1178-82. PubMed ID: 11607859
[No Abstract] [Full Text] [Related]
2. [Thalidomide: new uses for an old drug].
Wu KL; Sonneveld P
Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide: current and potential clinical applications.
Calabrese L; Fleischer AB
Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
[TBL] [Abstract][Full Text] [Related]
4. [The revival of thalidomide: an old drug with new indications].
Laffitte E
Rev Prat; 2006 Nov; 56(18):1977-83. PubMed ID: 17274497
[TBL] [Abstract][Full Text] [Related]
5. Dermatologic and nondermatologic uses of thalidomide.
Nasca MR; Micali G; Cheigh NH; West LE; West DP
Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
[TBL] [Abstract][Full Text] [Related]
6. Innovative uses of thalidomide.
Chen M; Doherty SD; Hsu S
Dermatol Clin; 2010 Jul; 28(3):577-86. PubMed ID: 20510766
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide makes a comeback.
Dodd-Butera T; Broderick M
RN; 2003 May; 66(5):32-5; quiz 36. PubMed ID: 12778690
[No Abstract] [Full Text] [Related]
8. Thalidomide: a review of approved and investigational uses.
Matthews SJ; McCoy C
Clin Ther; 2003 Feb; 25(2):342-95. PubMed ID: 12749503
[TBL] [Abstract][Full Text] [Related]
9. [The thalidomide story and its lessons].
Dolev E
Harefuah; 2001 Jul; 140(7):663-7. PubMed ID: 11481978
[No Abstract] [Full Text] [Related]
10. [An old drug as a carcinostatic. The new career of thalidomide].
Holzgrabe U
Pharm Unserer Zeit; 2007; 36(6):446-9. PubMed ID: 17957689
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide: mechanisms of action.
Paravar T; Lee DJ
Int Rev Immunol; 2008; 27(3):111-35. PubMed ID: 18437602
[TBL] [Abstract][Full Text] [Related]
12. Review of thalidomide use in the pediatric population.
Yang CS; Kim C; Antaya RJ
J Am Acad Dermatol; 2015 Apr; 72(4):703-11. PubMed ID: 25617013
[TBL] [Abstract][Full Text] [Related]
13. [Thalidomide: new perspectives for its use as antiinflammatory, immunossupressive and antiangiogenic drug].
Borges Lde G; Frõehlich PE
Rev Assoc Med Bras (1992); 2003; 49(1):96-102. PubMed ID: 12724820
[TBL] [Abstract][Full Text] [Related]
14. [Thalidomide--new prospective therapy in oncology].
Pałgan K; Pałgan I
Wiad Lek; 2003; 56(9-10):455-9. PubMed ID: 15049211
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of erythema nodosum leprosum using thalidomide].
Sheskin J
Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
[No Abstract] [Full Text] [Related]
16. [Thalidomide in oncological and hematological diseases].
Kivivuori SM; Anttila P
Duodecim; 2010; 126(12):1413-9. PubMed ID: 20617746
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide: is it any wonder?
Hampshire M
Nurs Times; 1998 Aug 26-Sep 1; 94(34):14-5. PubMed ID: 9791503
[No Abstract] [Full Text] [Related]
18. Thalidomide. A new beginning.
Valorie AM
Cancer Pract; 2000; 8(2):101-3. PubMed ID: 11898173
[No Abstract] [Full Text] [Related]
19. [Thalidomide--a dreaded drug with new indications].
Waage A; Seidel C
Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2954-7. PubMed ID: 11715779
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide and its dermatologic uses.
Moraes M; Russo G
Am J Med Sci; 2001 May; 321(5):321-6. PubMed ID: 11370795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]